Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).
about
Lung cancer induced from chemotherapy a 20 years old case.Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitorSpotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to dateTargeting rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitorsAnti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination StrategiesCanadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer
P2860
Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combination of immunotherapy w ...... mall cell lung cancer (NSCLC).
@en
Combination of immunotherapy w ...... ced non-small cell lung cancer
@nl
type
label
Combination of immunotherapy w ...... mall cell lung cancer (NSCLC).
@en
Combination of immunotherapy w ...... ced non-small cell lung cancer
@nl
prefLabel
Combination of immunotherapy w ...... mall cell lung cancer (NSCLC).
@en
Combination of immunotherapy w ...... ced non-small cell lung cancer
@nl
P2093
P2860
P356
P1476
Combination of immunotherapy w ...... mall cell lung cancer (NSCLC).
@en
P2093
Irene Moya-Horno
Niki Karachaliou
Santiago Viteri
P2860
P304
1758834017745012
P356
10.1177/1758834017745012
P577
2018-01-09T00:00:00Z